Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announcend that its Shivalik, Insignia and Vedant (except bio analytical) facility has successfully completed fifth inspection by WHO (World Health Organization) without any critical observations.

After successful inspection by NPRA (Malaysian Regulatory Agency), Veeda CRO faced another inspection in the same month by WHO. This inspection was the fifth WHO inspection at Veeda. WHO Inspectors did thorough inspection of all three Veeda facilities, wherein they reviewed various BE studies submitted as part of pre-qualification of BE-studies applications program. The Inspection team also covered various other study related activities as well as different facilities.

Veeda CRO have successfully faced 50 regulatory audits in last 13 years wherein 18 USFDA Inspections were conducted successfully in last 24 months which demonstrates our commitment levels towards Quality and Regulatory Compliance.

With an enhanced focus on 'Right First Time' approach, Veeda CR looks forward to a brighter future in Clinical Research Arena. These inspections are another testimony to Veeda CR's continuous quality review and improvement measures institutionalized into the work culture, the company has said in a release.